Basics Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines. IPO Date: March 26, 1990 Sector: Healthcare Industry: Pharma Market Cap: $18.4B Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 1.31% Avg Daily Range (30 D): $0.21 | 1.22% Avg Daily Range (90 D): $0.30 | 1.84% Institutional Daily Volume Avg Daily Volume: 7.69M Avg Daily Volume (30 D): 9.54M Avg Daily Volume (90 D): 10.36M Trade Size Avg Trade Size (Sh.): 241 Avg Trade Size (Sh.) (30 D): 239 Avg Trade Size (Sh.) (90 D): 197 Institutional Trades Total Inst.Trades: 78,929 Avg Inst. Trade: $2.27M Avg Inst. Trade (30 D): $2.31M Avg Inst. Trade (90 D): $2.99M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 14 Market Closing Trades Avg Closing Trade: $5.31M Avg Closing Trade (30 D): $9.71M Avg Closing Trade (90 D): $10.42M Avg Closing Volume: 258.32K     News Jul 18, 2025 @ 7:06 AM Billionaire Stanley Druckenmiller Sold His Entire ... Source: Sean Williams Jun 26, 2025 @ 3:44 PM The $900 Billion Question: Who Will Deliver the Ne... Source: Prnewswire Jun 16, 2025 @ 7:06 AM Billionaire Stanley Druckenmiller Dumped His Entir... Source: The Motley Fool Jun 9, 2025 @ 8:56 AM Selective Estrogen Receptor Modulators Market Rese... Source: Researchandmarkets.Com Jun 6, 2025 @ 5:31 PM Goldman Sachs Bullish On Branded Drug Upside At Te... Source: Vandana Singh Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.14 $.19 $-.19 Diluted EPS $-1.15 $.18 $-.19 Revenue $ 16.62B $ 3.89B $ 4.23B Gross Profit $ 8.17B $ 1.88B $ 2.12B Net Income / Loss $ -1319M $ 220M $ -275M Operating Income / Loss $ 434M $ 519M $ -29M Cost of Revenue $ 8.45B $ 2.01B $ 2.11B Net Cash Flow $ -2455M $ -1603M $ -18M PE Ratio     Splits Jul 01, 2004:   2:1 Dec 06, 2002:   2:1 Feb 23, 2000:   2:1